Isabelle Texier-Nogues

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 19 EPO patents. Top assignees: Commissariat a L'energie Atomique Et Aux Energies Alternatives, Centre National De La Recherche Scientifique, National Institute of Health and Medical Research. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Texier-Nogues. Retrieved from https://idiyas.com/inventor/isabelle-texier-nogues

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 70.6

CIPO Patents = 2

EPO Patents = 19 (Patent Applications = 26)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

16 out of 8,827

Commissariat a L'energie Atomique Et Aux Energies Alternatives

patents

2 out of 5,383

Centre National De La Recherche Scientifique

patents

2 out of 1,853

National Institute of Health and Medical Research

patents

4. 1 out of 132

Centre National De La Recherche Scientifique

patents

5. 1 out of 1

The Joseph Fourier University of Grenoble

patent

6. 1 out of 179

Université Grenoble Alpes

patents

7. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2026

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12674006 - Modified hyaluronic acid as dopant for PEDOT and/or PProDOT polymers (2026-07-07),

2. 10092506 - Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion (2018-10-09),

3. 10016510 - Immunogenic composition in emulsion form (2018-07-10),

4. 9707305 - Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis (2017-07-18),

5. 9463248 - Material, method for preparing same, and uses thereof (2016-10-11),

6. 9421281 - Target vector with activable imaging function (2016-08-23),

7. 9289517 - Fluorescent emulsion of indocyanine green (2016-03-22),

8. 9180210 - Nanocrystal nano-emulsion (2015-11-10),

9. 9072775 - Fluorescent emulsions for optical imaging (2015-07-07),

10. 8653291 - Method for surface functionalization by disubstituted alkynes (2014-02-18),

11. 8652360 - Semiconductor nanocrystals (2014-02-18),

12. 8592619 - Bifunctional molecules comprising a cycloalkyne or heterocycloalkyne group and a redox group (2013-11-26),

13. 8546598 - Silane compounds having a cyclic carbon chain including an alkyne function for functionalizing solid substrates and immobilizing biological molecules on said substrates (2013-10-01),

14. 8541604 - Process for the functionalization of biological molecules (2013-09-24),

15. 8513394 - Saccharide fluorescent substrates, preparation method and uses thereof (2013-08-20),

Title: The Innovative Contributions of Isabelle Texier-Nogues

Introduction

Isabelle Texier-Nogues is a prominent inventor based in Grenoble, France. She has made significant contributions to the field of therapeutic agent formulations, holding a total of 17 patents. Her work focuses on the development of innovative solutions that enhance the efficacy of therapeutic agents.

Latest Patents

One of her latest patents is titled "Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion." This invention relates to a therapeutic agent formulation in the form of a nano-emulsion, which comprises a continuous aqueous phase and at least one dispersed oily phase. The oily phase includes not only the therapeutic agent but also at least one amphiphilic lipid and one solubilizing lipid. The aqueous phase contains at least one polyalkoxylated cosurfactant. Another notable patent is the "Immunogenic composition in emulsion form," which involves an immunogenic composition comprising a continuous aqueous phase and a dispersed phase as droplets.

Career Highlights

Isabelle has worked with esteemed organizations such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and the Commissariat à l'Énergie Atomique. Her experience in these institutions has allowed her to develop and refine her innovative ideas in the field of therapeutic formulations.

Collaborations

Throughout her career, Isabelle has collaborated with talented individuals, including Aude Bernardin and Mathieu Goutayer. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Isabelle Texier-Nogues is a remarkable inventor whose work in therapeutic agent formulations has led to significant advancements in the field. Her innovative patents and collaborations highlight her dedication to improving healthcare solutions.

Profile summary based on public USPTO records.